BlackRock, Inc.

Position in HIMS — Hims & Hers Health, Inc.

CIK 2012383 New York, NY

Position in HIMS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$995,150,823

+$448,391,433 QoQ

Shares Held

28,703,514

+9.0% QoQ

Ownership

12.3%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

of 507 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $21,635,633,053 across 65 Drug Manufacturers - Specialty & Generic names. HIMS ranks #8 (4.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	5,294,529	$2,868,734,637
2	ZTS	Zoetis Inc.	39,430,181	$2,833,452,797
3	NBIX	Neurocrine Biosciences Inc	13,711,607	$2,310,954,234
4	TEVA	Teva Pharmaceutical Industries Ltd	63,894,301	$2,164,738,910
5	ALKS	Alkermes plc.	29,235,739	$1,531,952,715
6	VTRS	Viatris Inc	86,019,468	$1,365,989,144
7	ELAN	Elanco Animal Health Inc	48,849,973	$1,202,197,829
8	HIMS	Hims & Hers Health, Inc. This page	28,703,514	$995,150,823

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$995,150,823	28,703,514	+9.0%	Shares	Sole	2026-08-07
2026-03-31	$546,759,390	26,337,158	-0.9%	Shares	Sole	2026-05-13
2025-12-31	$862,841,666	26,573,504	+5.7%	Shares	Sole	2026-02-12
2025-09-30	$1,426,270,562	25,145,814	+1.6%	Shares	Sole	2025-11-12
2025-06-30	$1,233,756,286	24,749,374	+2.1%	Shares	Sole	2025-08-12
2025-03-31	$716,429,015	24,244,637	-19.5%	Shares	Sole	2025-05-02
2024-12-31	$727,999,898	30,107,523	+95.3%	Shares	Sole	2025-02-07
2024-09-30	$284,008,854	15,418,505	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.